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INTRODUCTION 
 
Emphysematous pyelonephritis was first reported by 
Kelly and MacCallum in 18981 and was considered to be rare. The 
term EPN was first used by Schultz and Klorfein 2 and is applied 
when gas is formed only in or around the kidney3. The lack of a 
strict definition of EPN has resulted in the use of multiplicity of 
terms, such as renal emphysema, pneumonephritis, pyelonephritis 
emphysematosa and pneumonephrogram. As suggested by Schultz 
and Klorfein, emphysematous pyelonephritis is the preferred 
designation4.     
 Gas-forming bacteria using glucose as a substrate 
cause necrotizing lesions in infected tissue, especially in diabetic 
patients or those with an obstructive urinary tract infection. EPN 
can be complicated by acute sepsis, resulting in a poor prognosis. 
Thus the disease presents a urologic emergency5. It deserves 
special attention because of its life-threatening potential. Mortality 
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rates associated with Emphysematous pyelonephritis vary from 7 
to 75% 6,7 .   
It has generally been regarded as a rare infection in the 
earlier reports. However, with the more extensive use of 
ultrasonography and computed tomography in the evaluation of 
patients with features of sepsis or complicated urinary tract 
infection (UTI), more cases of Emphysematous pyelonephritis 
(EPN) are being recognized. Huang et al believe that EPN is not 
rare and should be considered an important clinical entity 8. 
 Traditional therapy for emphysematous pyelonephritis 
was nephrectomy or open surgical drainage and appropriate 
antibiotics6. Hudson et al first described fluoroscopic guided 
percutaneous drainage for the treatment of emphysematous 
pyelonephritis9. The definitive treatment is nephrectomy. In 
patients with a general condition that prevents them from tolerating 
general anesthesia, medical therapy consisting of intravenous 
antibiotics and glycemic control measures with or without 
percutaneous drainage is often applied. However this is a disease 
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that most commonly affects diabetics- a systemic disease with 
proven hazardous effect over the other uninvolved kidney in the 
long run. Moreover emphysematous pyelonephritis can be a 
bilateral problem in 10%10 and can affect solitary kidneys. These 
are the instances when renal conservation becomes more 
preferable. 
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AIMS AND OBJECTIVES 
 
 
1) To study the feasibility of renal conservation in 
emphysematous pyelonephritis. 
 2) To analyse the various prognostic factors that favour renal 
conservation in emphysematous pyelonephritis. 
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REVIEW OF LITERATURE 
 
Definition: 
Emphysematous pyelonephritis is a severe acute 
bacterial infection of the kidney characterized the presence of gas 
within the renal parenchyma, collecting system or perinephric 
tissue 6,11 . 
 Controversy still exists on whether distinguishing gas 
accumulation within the renal parenchyma from gas in the 
perinephric tissue is necessary.  
Some investigators suggested that the term emphysematous 
pyelonephritis should be applied only to gas formed within the 
renal parenchyma, whereas most prefer to include both conditions 
under the same designation6. The latter definition is favoured 
because it includes all the possible manifestations of gas-forming 
acute renal infections 8.  
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Sites: 
Gas-forming infections can develop anywhere in the 
upper or lower urinary tracts, as follows:  
1. in the renal parenchyma (emphysematous nephritis) 
2. calyx and pelvis (emphysematous pyelitis) 
3. ureter(emphysematous ureteritis)  
4. urinary bladder (emphysematous cystitis) 12.  
 
Etiology: 
             Emphysematous pyelonephritis occurs almost exclusively 
in patients with diabetes mellitus(DM),but occasionally in patients 
without DM along with obstruction of the corresponding 
renoureteral unit 8,11,13,12.  
In 1941 Gillies and Flocks stated that three factors are 
essential for spontaneous gas formation in the kidney:      
1) Obstruction of the urinary tract 
 2) Uncontrolled diabetes mellitus  
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3) Gas producing organisms 6  
4) Defective immune system 6,14 . 
                            
Causative organisms: 
The main causative organisms in EPN are those normally found in 
urinary and gastrointestinal tracts. In the study by Michaeli et al 6, 
Escherichia coli was the most common organism (71%). In 19% of the 
cases >1 organism was present. Aerobacter aerogenes and Proteus 
mirabilis were isolated in some patients. Whenever an organism was 
found in the kidney at operation it was identical to that found in urine 
culture. Anaerobic bacteria were grown only in 1 of 54 cases 6.In the 
study by Huang et al, pathogens was identified in 98% of cases. E.coli 
was the commonest organism isolated (69%), K.pneumoniae was the 
second (29%). Two patients out of 48 had E.coli infection mixed with 
Streptococcus spp. or Proteus spp. Anaerobic organisms were not 
obtained 8.Thus the most common organism grown is E.coli followed by 
Klebsiella. Proteus, Pseudomonas, Aerobacter aerogenes ,Streptococcus 
and rarely anaerobes, Candida albicans and Cryptococcus may be 
grown15. 
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Role of diabetes mellitus: 
EPN most commonly occurs in diabetics. Diabetic 
patients are compromised hosts and they have an impaired defense 
mechanism for bacterial infection14.In Michaeli et al’s study, 
diabetes mellitus occurred in 87 of the patients. Though it has long 
been postulated that EPN is found exclusively in uncontrolled 
diabetics, it has also been reported in non diabetics and diabetics 
with excellent diabetes control. In the non diabetic patients, EPN is 
almost always associated with ureteral obstruction6. It has been 
postulated that high tissue glucose levels provide the substrate for 
the organisms to produce carbon dioxide and hydrogen via the 
fermentation of sugar6.   
 
The role of obstruction 
Obstruction was present only in 40% of patients of 
Michaeli et al 6. He refutes the notion that obstruction of the 
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urinary tract is necessary for gas formation. However, most of the 
patients with bilateral EPN and EPN in solitary kidneys had 
urinary tract obstruction. In the non diabetic patient, EPN nearly 
always is associated with ureteral obstruction6. In Huang et al’s 
study, 22% of diabetics and all the non diabetics (2 patients) had 
associated urinary tract obstruction. Urinary tract obstruction also 
occurred more frequently in the left kidney than the right one (64% 
vs 36%)8.     
 
Pathophysiology 
It has been postulated that high tissue glucose levels 
provide the substrate for the organisms to produce carbon dioxide 
and hydrogen via the fermentation of sugar6.   
Two important features found commonly in EPN are 
severe necrotizing infection and impaired vascular supply 
manifested by intrarenal thrombi and renal infarctions. These 
findings support the theory of  Schainuck and associates16, 
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emphasizing the importance of impaired tissue and vascular 
response, which enables organisms capable of producing carbon 
dioxide to use necrotic tissue as a substrate for gas generation. 
Local factors (obstruction and diabetic glomerulopathy) and 
systemic factors (increased risk of infectious complications 
associated with diabetes mellitus) contribute to tissue and vascular 
damage. Accordingly, it is the impaired host response and not 
hyperglycemia per se that predisposes to gas production in necrotic 
tissue. It has been suggested that gas formation may not associated 
inevitably with infection. The impaired host response theory is a 
feasible explanation for the presence of EPN in patients without 
diabetes or, possibly, even in those without evidence of infection. 
In patients with diabetes mellitus and EPN both mechanisms 
(sugar fermentation and defective host response) may coexist and 
explain the origin of profuse gas production6.  
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Mechanism of Gas Formation 
The actual mechanism of gas formation is controversial. Growing 
organisms require a constant supply of metabolic energy. The 
bacteria obtain their energy through fermentation of glucose. This 
proceeds via the glycolytic (Embden-Meyerhof) pathway, by 
which two molecules of adenosine triphosphate (ATP) are 
produced, nicotinamide adenine dinucleotide (NAD+) is converted 
to nicotinamide adenine nucleotide dehydrogenase (NADH), and 
pyruvate is generated in the process as end product. A variety of 
pathways have evolved in the microorganism for the reoxidation of 
NADH by pyruvate or its derivative. These pathways include lactic 
fermentation (streptococcus, lactobacillus), Alcoholic fermentation 
(many Yeasts, a few bacteria), mixed acid (formic acid) 
fermentation (most Enterobacteriaceae), butyric fermentation 
(Clostridium), butanediol fermentation (Enterobacter) and 
propionic fermentation (Propionibacterium).The formate produced 
by Enterobacteriaceae spp. in mixed acid fermentation is 
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relatively stable in alkaline pH. However the fermentation 
reactions lead to the accumulation of acids and when the pH 
reaches 6 or below, a gas forming microorganism like E.coli, will 
form an enzyme, formic hydrogenylase, which converts formic 
acid into carbon dioxide and hydrogen. The production of 
hydrogen is the hallmark of mixed acid fermentation because none 
of the other 5 pathways  listed would give rise to hydrogen gas as 
the end product. Considering the natural tendency for the gas 
composition of a gas bubble to equilibrate with the surrounding 
tissue, it is reasonable that the gas will contain reasonable amounts 
of  nitrogen, as well as oxygen, carbon dioxide and hydrogen, trace 
amounts of ammonia and methane might arise from the 
fermentation of mixed amino acids that were produced by the 
degradation of the necrotic tissue14.  Rarely butyric fermentation of 
glucose by anaerobes could contribute to the gas. 
The mechanism of gas chamber(i.e, large gas bubbles) 
formation has been hypothesized as a series of increased gas 
production, impaired transportation of gas by vascular 
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compromise, creation of a gas chamber, equilibrium of gas 
chamber and tissue gas, and the expansion or collapse of the gas 
chamber.  
Four factors that may be involved in the pathogenesis 
of EPN include gas forming bacteria, high tissue glucose levels, 
impaired tissue perfusion, and a defective immune response. High 
tissue glucose levels in patients with DM may provide gas forming 
microbes with a microenvironment more favourable for their 
growth and rapid catabolism, which can cause the massive 
production of gas 14,17,18 . In case of urinary tract obstruction , the 
unrelieved obstruction and hydronephrosis may increase the 
pelvicalyceal pressure and compromise renal circulation, and result 
in impaired transportation of gas and subsequent creation of a gas 
chamber(ie, EPN)8. Yang and Shen14 indicated that gas forming 
infection depends on rapid catabolism and impaired transport of 
end products at the site of inflammation. Local tissue damage 
caused by the gas forming bacteria, compounded by the diabetic 
microangiopathy, would perhaps markedly retard the transport of 
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catabolic end products away from the lesion and thereby result in 
the accumulation of gas. In the non-diabetic also, glucose may 
serve as the substrate for gas formation. In normal non-diabetics, 
around 20 mg% of glucose may be present and upto 60 mg% with 
acute or chronic renal disease. Subclinical glucosuria in renal 
infection may be enough to generate sufficient amounts of gas[12 
to 36 cc of gas from 100 mg glucose at S.T.P] 2. Gas in the urinary 
tract may originate from bacteria, a fistula between the urinary and 
gastrointestinal tracts or direct exposure to atmospheric air due to 
trauma or instrumentation 12. 
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Fig 1:Pathogenesis of emphysematous urinary tract 
infection14 
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 PATHOLOGY 
 
1) Severe acute and chronic necrotizing pyelonephritis 
and multiple cortical abscesses. 
2) Papillary necrosis. 
3) Acute inflammatory cell infiltration with focal necrosis      and 
abscess formation. 
4) Evidence of impairment of tissue circulation – infarction, 
vascular thrombosis, arteriosclerosis and glomerulosclerosis. 
5) Features of diabetic nephropathy – Kimmelstiel-Wilson nodules, 
hyalinized arteriosclerosis and glomerulosclerosis. 
               The inflammatory findings are limited to the kidney in 
class 2 EPN, but extend to the perinephric areas in more severe 
cases. 
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CLASSIFICATION 
Wan et al 
Type I 
Renal necrosis with either total absence of fluid content on CT or 
the presence of a streaky/mottled gas pattern demonstrated on 
radiograph or CT with lung window display. 
Type II 
Characterized either by the presence of renal/perirenal fluid in 
association with a bubbly/loculated gas pattern or by the presence 
of gas in the collecting system. 
Type I emphysematous pyelonephritis is associated with more 
extensive parenchymal necrosis and a more fulminating clinical 
course than type II 7 
Huang et al Classification. 
  Class 1 – Gas in the collecting system only (Emphysematous 
pyelitis) 
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Class 2 – Gas in the renal parenchyma without extension into 
the extrarenal space 
Class 3A- Extension of gas or abscess to the perinephric space 
Class 3B- Extension of gas or abscess to the pararenal space 
Class 4 – Bilateral EPN/Solitary kidney with EPN 8 
 
Michaeli et al classification 
Stage I- Gas within the renal parenchyma or in the perinephric 
tissues. 
Stage II- Presence of gas in the kidney and its surroundings. 
Stage III- Extension of gas through Gerota’s fascia or 
presence of bilateral EPN. 
 
Mitra et al classified renal emphysema into two 
distinct entities and claimed that this classification had important 
prognostic and therapeutic implications. 
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1) Emphysematous pyelitis : A milder form with gas limited 
to the renal pelvicalyceal system. It is commonly associated 
with obstructive uropathy6,19. It responds well to 
conservative mode of therapy with or without a drainage 
procedure. 
2) Emphysematous pyelonephritis : Gas extends further into 
the renal parenchyma, perinephric tissues and to 
retroperitoneum. It is a serious clinical condition with a high 
mortality and morbidity. In addition to medical treatment 
more aggressive surgical management viz., nephrectomy 
has been recommended to improve survival 15. 
 
CLINICAL PRESENTATION 
EPN presents mostly in adults 20.Juvenile diabetics do 
not appear to be at risk. Women are affected more often than men 
21. The usual clinical presentation is severe, acute pyelonephritis 
that fails to resolve during the first 3 days of treatment. In some 
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cases, a chronic infection precedes an acute attack. Almost all 
patients display the classic triad of fever, vomiting and flank 
pain16. Pneumaturia is absent unless the infection involves the 
collecting system. Results of urine cultures are invariably positive. 
Most frequently identified organism is E.coli; Klebsiella and 
Proteus are less common. Michaeli, in his review of 55 patients 
reported chills, fever(56%) , flank pain(48%) , Lethargy and 
confusion(24%) , Nausea and vomiting (16%), shock and 
coma(16%). Fever of unknown origin was the presenting feature in 
18%. Pneumaturia was not very common. The average duration of 
symptoms before diagnosis was 21 days- the range being  0.5 to 
240 days6. Huang et al reported fever in 79%, nausea/vomiting in 
17% shock in 29%, altered consciousness in 19% and acute renal 
functional impairment in 35% of patients 8. 
The incidence of diabetes was very high, 80%(Shokeir 
et al 12),  96%(Huang et al 8), and  87%(Michaeli et  al 6). 
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The side of involvement was predominantly left ( 60% in 
Shokeir et al’s study12 and  47% (Bum Soo Park et 
al)5..Bilateral presentation ranged from 5% 12 to 20% 22. 
The most common localizing sign is costovertebral angle 
tenderness5. Leukocytosis is seen in about 67% and 
thrombocytopenia in 46%8. Patients may present in a state of 
medical emergency viz., diabetic ketoacidosis. 
MICROBIOLOGY 
The most common organism grown is E.coli (69% to 71%) 
followed by Klebsiella (29%)8,6. Bacteremia is found in almost half 
of all the cases and usually the same organisms are grown in urine , 
blood  and tissue cultures8,12. More than one organism is isolated in 
around 19% of cases6. 
RADIOLOGY 
The definitive modality of diagnosis of EPN is 
radiology. Radiology not only confirms the diagnosis, but also 
helps to classify EPN hence guiding the management and 
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prognostication of the disease. X-ray, USG and CT scan all help in 
the diagnosis. CT is the best modality for confirmation of the 
diagnosis. It defines the extent of gas dissemination very 
accurately and rapidly. It can precisely stage the gas distribution. 
The USG [Ultrasonogram] helps in diagnosis of 
urinary tract obstruction, but may not be very sensitive to detect 
renal gas. USG demonstrates the intraparenchymal gas in the form 
of strong focal echoes23,24. USG is readily available, non invasive 
and cheap. The disadvantage is that it cannot measure the depth of 
gas collections and due to the dense echoes at the acoustic 
interface with total lack of penetration deep to the gas collections3. 
USG is less reliable in diagnosing this condition compared to CT 
scan.   
Plain X-ray of the KUB region demonstrated gas in 
the region of the kidney and perirenal areas in 33% of cases. 
Infusion nephrotomography can be utilized to differentiate renal 
gas from overlying intestinal gas in equivocal cases6. 
IVU[Intravenous urogram] demonstrates non visualization in 
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around 45%. Even in those who showed excretion, majority 
showed a poor delineation. Due to the hazardous consequences of 
IV contrast on the kidneys in diabetics and due to the fact that not 
much information is provided by it (because the affected system is 
usually non functioning or poorly functioning) when compared to 
CT, its use should weighed judiciously. In addition to 
demonstrating renal gas, IVU may show other findings suggestive 
of renal inflammation like indistinct margins and mass effect12. 
Obstruction is demonstrated in around 25% of cases 21 and is better 
demonstrated by USG or retrograde pyelogram. 
                   3 main patterns were described on X-rays by Langston 
and Pfister that had an apparent correlation with the stage of the 
disease. Diffuse mottling of the renal parenchyma, with radial 
distribution of the gas bubbles either along the pyramids or within 
the tubules was the earliest sign. Bubbly parenchyma surrounded 
by a crescent of gas is the manifestation of renal necrosis and this 
finding denotes further clinical deterioration. With extension  
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through the Gerota’s fascia , gas can be seen in the retroperitoneum 
and may even extend upto the posterior thoracic wall25. 
Bum Soo Park et al found plain Xray KUB reliable as 
the initial modality for screening (picked up 50% of cases)  and CT 
the most reliable modality for confirmation of the diagnosis 
(Diagnostic rate 100%) and for planning treatment. They consider 
USG unhelpful to locate renal gas5.  
 
MANAGEMENT 
Patients with EPN are acutely ill and supportive 
measures should be rapid. Vigorous measures aimed at glycaemic 
control, maintenance of fluid balance and treatment of shock 
should be initiated as quickly as possible. Empirical broad 
spectrum antibiotics should be started when the diagnosis is 
suspected and the antibiotics can be tailored according to 
sensitivity once culture results are available. Obstruction, if 
present, should be relieved urgently. 
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                 According to Schultz and Klorfein, the disease is best 
treated by conventional medical methods and is not an indication 
of emergency surgery. They concluded that contralateral disease 
was often present and nephrectomy was unwarranted2. 
Joseph.B.Stokes JR26, Dunn and Dewolf et al, in their study of 3 
cases treated by nephrectomy27 favoured an initial trial of 
conservative management with antibiotics. Their main concern was 
the possibility of recurrent disease in the contralateral kidney. 
Nephrectomy could be considered if the renal and perirenal gas or 
the toxic symptoms persist. They suggested that such patients be 
started on lifelong suppressive antibiotics and be followed up 
strictly. They concluded that medical management of EPN was 
preferable due to the high chances of the opposite kidney being 
involved, especially in diabetics. Avoidance of surgery, vigorous 
blood sugar control, appropriate antibiotics and relief of 
obstruction was rational. 
            Traditionally the consensus was that mere medical 
treatment was ineffective and prompt surgical drainage was 
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recommended and nephrectomy was often necessary. Mortality 
rate in patients who are treated only with antibiotics is 40%. 
Treatment is successful in 66% of patients who are treated with 
percutaneous  nephrostomy and antibiotics, and in 90% of those 
with nephrectomy 28.Renal conservation has come into vogue for 
reasons already mentioned. The need to save the kidney in the 
setting of a high probability of the disease occuring in the opposite 
side later as well as the long term effects of diabetes on the 
opposite kidney. Patients presenting with synchronous bilateral 
disease as well as EPN affecting a solitary kidney present 
unenviable situations where renal conservation is highly desirable. 
Huang et al8 emphasized the importance of 
perinephric extension of gas. Even though the differences in 
clinical features among the 4 classes was not significant , there was 
a tendency towards higher mortality and failure of PCD from class 
1 to 4. The best prognosis was enjoyed by class 1 patients. All of 
them survived with PCD and antibiotics with relief of obstruction 
whenever necessary. In class 2 also, all patients treated so, were 
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cured. For patients with extension of gas beyond renal parenchyma  
or bilateral EPN (class 3 and 4), 85% of patients with <2 risk 
factors (thrombocytopenia, acute renal functional impairment, 
disturbed consciousness and shock) successfully responded to PCD 
and antibiotics. The failure rate of conservative treatment (i.e., 
combined medical and minimally invasive treatment) was 15% for 
those with no or a single risk factor and 92% for those with 2 or 
more risk factors. In such cases, nephrectomy is expected to give 
the best management outcome. The advantages of PCD are that it 
drains the pus, releases the gas and hence the pressure to local 
circulation, provides pus that can be cultured and can help in 
further management and can provide increased rates of success in 
extensive EPN. They suggest PCD and antibiotics less extensive 
disease (class 1 & 2) and for extensive EPN with < 2 risk factors. 
This leads to a renal conservation in most of the cases. 
Nephrectomy provided the best treatment outcome for extensive 
EPN with fulminant course (2 or more risk factors). In managing 
class 4 EPN, bilateral PCD should be tried first. Emergency 
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nephrectomy carries a high risk in these patients. Nephrectomy 
should be done if  PCD fails. 
                    Poor glycaemic control was not a poor prognostic 
factor. Patients seen initially with organ systems dysfunction ran a 
rapid course with poor outcome. Severe proteinuria correlated with 
poor outcome and seemed to be a risk factor for extensive disease. 
The causes of severe proteinuria may be multifactorial with fever, 
underlying glomerulonephritis, and diabetic nephropathy may 
contribute. 
                     Michaeli et al6, in their review, state that attempts at    
renal conservation were often not successful. But even bilateral 
surgery was successful at times. The most important factor 
associated with survival was an approach combining  medical and 
surgical treatment. They inferred that the most favourable outlook 
was presented by a patient receiving combined medical and 
surgical treatment for nonobstructive unilateral disease following a 
short interval of symptoms.                                                                                
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                       Wan et al described two classes of EPN7. The dry 
type (type 1) was associated with destruction of parenchyma, 
absence of fluid collection and streaky or mottled gas presented a 
fulminant course with a mortality rate of 69%.  Type 2 had renal or 
perinephric fluid collection with bubbly or loculated gas and was 
associated with a mortality rate of 18%.  This difference was 
probably due to immune compromise and vascular insufficiency in 
the kidneys and immunodeficiency in the diabetics. They described 
serum creatinine > 1.4mg%  was associated with a poor outcome. 
                 In their study of 20 cases, Shokeir et al12 conclude that  
nephrectomy should immediately follow aggressive resuscitation 
and diabetes control. Even if the patient begins to improve, delay 
of nephrectomy is inappropriate because it jeopardizes the chances 
for survival. With this protocol of treatment, survival rates reached  
80%. 
Stein et al, in their case report and review of 
literature22, subdivided  treatment of bilateral disease into three 
groups: (1) those managed with medical therapy alone (without 
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surgical intervention); (2) those managed with unilateral surgical 
intervention (incision and drainage and or nephrectomy) to one 
kidney; and (3) those managed with bilateral surgical intervention, 
(bilateral incision and drainage, ipsilateral nephrectomy, and 
contralateral incision and drainage, and bilateral nephrectomy) . 
They concluded that there appeared to be a survival advantage if 
bilateral surgical intervention is performed with the intent to spare 
some renal function in patients with bilateral emphysematous 
pyelonephritis. This may include bilateral incision and drainage if 
there is minimal bilateral intraparenchymal involvement of gas 
without evidence of perinephric or adjacent organ involvement. 
When one renal unit is more extensively involved with or without 
perinephric gas, ipsilateral nephrectomy with contralateral incision 
and drainage may be appropriate with close radiographic 
monitoring of the remaining kidney If there is no resolution of 
intraparenchymal gas or progression postoperatively, then 
nephrectomy of the solitary kidney may be indicated. Bilateral 
nephrectomy should be reserved for those individuals with severe 
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bilateral disease with extensive renal parenchymal and perinephric 
extension of gas, as this renders the patient anephric and dialysis 
dependent.However, the small number of cases in the study may be 
a limiting factor to draw conclusions. High thoracoabdominal 
incision was preferred by Stein et al. It provided them with  
maximum exposure, allowed quick intraperitoneal access to the 
renal vessels, which should be secured first. 
Bum Soo Park et al5 consider nephrectomy to be the 
most effective modality of treating EPN. They  were for immediate 
nephrectomy and all supportive and resuscitative measures were to 
be carried concomitantly. Their indications for renal conservation 
(with PCD and antibiotics) were solitary kidney, poor 
general/medical condition rendering the patient unfit for surgery, 
inadequate contralateral kidney and bilateral disease. For 
nephrectomy, they preferred a 11th rib bed approach through the 
loin. 
Hung et al 29  have noted  anaerobic bacteria, B. 
fragilis as the causative organism in a case of EPN. Anaerobic 
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bacteria had never been found to be a causative pathogen except in 
one case with Clostridium30. They consider ascent and invasion of 
anaerobes  indigenous to the lower urethra, or a  spread from  
adjacent organs such as the bowel or uterus as the probable source. 
The presence of obstruction may  reduce the oxygen tension and 
impair tissue immunity and might predispose to EPN8. Hence they 
recommend that empirical treatment should also cover anaerobes 
in obstruction-related EPN. 
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MATERIALS and METHODS 
 
This was a prospective study conducted in Kilpauk Medical 
College in its constituent hospitals Kilpauk Medical College 
Hospital and Government Royapettah Hospital from September 
2004 to April 2007. 
 
Inclusion criteria 
1) Patients with features of acute pyelonephritis with gas in the 
renal parenchyma and beyond it. 
The symptoms were Fever, chills, loin pain, vomiting. 
2) Patients admitted in the emergency, but subsequently evaluated 
and found to have gas in the renal parenchyma and beyond it with 
features of acute pyelonephritis  
Exclusion criteria 
1) Patients with features of acute pyelonephritis without gas in the 
renal parenchyma. 
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2) History of recent endoscopic or open interventions in the urinary 
tract.      
3) History of recent catheterization. 
                           
Fig 2: Management protocol 
 
                           
   X ray / USG / CT scan
Emphysematous  pyelonephritis 
Fever / vomiting / flank pain
Conservative  Management 
No response Response 
Nephrectomy
Resuscitation 
Antibiotics   
DM control  
PCD 
DJ stenting 
Continue 
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All the patients who presented with fever, loin pain  
and vomiting underwent preliminary Xray KUB and USG 
abdomen. If findings suspicious of gas were present, they 
underwent CT KUB (with contrast enhancement if the renal 
parameters were not raised. Patients in whom gas could not be 
identified in either of these modalities underwent CT KUB based 
on clinical suspicion due to toxic clinical features. The patients 
were stratified based on Huang et al’s CT classification8. 
On admission, baseline characteristics recorded 
included age, sex, history, duration of and treatment for diabetes 
mellitus, and duration of symptoms. The clinical features recorded 
included hemodynamic status, the degree of consciousness, 
hydration status. Blood glucose level, serum creatinine, blood urea, 
total  and differential WBC counts,  blood haemoglobin level and 
urine acetone were recorded on admission. A blood platelet count 
was done. 
   Shock was defined as systolic BP <90 mm Hg. 
Raised renal parameter was defined as serum creatinine > 1.5 mg%  
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or blood urea >40mg%. Altered consciousness was defined as 
patient in confusion, delirium, stupor or coma. 
         All patients were started on 3rd generation 
cephalosporins (cefotaxime, ceftriaxone or cefoperazone) and 
metrogyl. Aminoglycosides were added if renal parameters were 
normal. Antibiotics were later changed if necessary, based on 
culture and sensitivity. Vigorous resuscitation was carried out with 
hydration, correction of electrolyte imbalance if any and diabetes 
control measures was initiated with insulin in all the cases. 
 All patients were stratified to initially undergo 
conservative management with only antibiotics, antibiotics with 
PCD &/or DJ stenting. PCD was defined as percutaneous 
aspiration of pus and gas with/without percutaneous nephrostomy. 
PCN was done under USG guidance using a 8.5Fr single puncture 
nephrostomy catheter in prone, prone oblique or lateral positions 
via the flank taking care to avoid contamination of the peritoneum. 
Unsuccessful PCD was defined as progressive or persistent lesions 
on radiological studies with a clinical picture of unstable 
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hemodynamic status or prolonged fever after management. Our 
patients, depending on outcome, were stratified into the “good” 
and “poor” outcome groups. The “good” outcome group included 
patients treated with antibiotics only or PCD +/_ DJ stenting or DJ 
stenting only with antibiotics. The “poor” outcome group included 
patients  who had unsuccessful PCD followed by nephrectomy or 
mortality.   
 
Statistical analysis: 
 
In the first step, descriptive analysis was done. 
Parametric variables such as age, disease duration, were expressed 
as mean and standard deviation and non-parametric variables such 
as sex, presence of diabetes mellitus, were expressed as 
proportions. They were presented in the form of tables and graphs.  
In the second step bivariate analysis was done 
between outcome and various other independent factors. For non-
parametric variables, chi square test was used and for parametric 
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variables student’s t test was used to assess the statistical 
significance.  
The patients were stratified into 2 groups based on a 
cutoff value for serum creatinine, platelet count, and total 
count.The cutoff values were selected to be the upper limits of the 
normal. Chi square test was used to assess the statistical 
significance.  
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PROFORMA 
 
Name                                                Date of admission 
IP no                                                 Date of discharge 
Age 
Sex 
Complaints 
Duration of symptoms 
H/O DM (along with duration and treatment) 
Clinical examination 
Investigations at presentation 
         Blood sugar 
         Serum creatinine & Blood urea 
         Total WBC count & hemoglobin 
         Platelet count 
         Urine acetone 
         Urine culture & sensitivity 
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          Blood culture 
         Mode of diagnosis 
         CT class 
          Presence of obstruction 
         Treatment category 
         Antibiotics used 
         Outcome 
         Number of days of hospital stay   
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RESULTS 
 
Fig 3:Descriptive Statistics 
  N Minimum Maximum Mean Std. Deviation 
Age 25 38 82 55.12 9.71 
Duration(days) 25 3 60 11.60 11.02 
DM duration 20 3 27 9.50 5.65 
Blood sugar 25 92 474 246.92 96.27 
Se.Creatinine 25 0.6 4.3 1.84 1.04 
Bl.Urea 24 15 116 52.54 25.80 
Platelet 25 50000 220000 142400.00 44654.23 
TC 24 6000 15600 10945.83 2963.98 
HB 25 7.2 12.6 9.94 1.53 
Hospital_stay 25 6 44 18.76 8.39 
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This table gives the descriptive statistics of the study population 
and their derived variables including the mean, standard deviation 
and maximum and minimum values. 
 
Sample size:  
Total number of patients included in this study was 25. 
Age:  
The mean age was 55.12 yrs with a standard deviation of 9.71.The 
youngest patient was 38 yrs and the oldest was 82 yrs old. Age was 
not significantly related to the outcomes in our study (p=0.094). 
Sex: 
62% of the total cases were males and 32% were females. There 
was no significant relationship between sex and outcomes 
(p=0.0607) (Fig 4). 
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 Sex Distribution
Female
)68% (17
Male
)32% (8
 
Figure 4: Sex distribution 
frequency of side affected
Bilateral, 2, 8%
 Left
)52% (13
Right
)40% (10
 
Figure 5: Frequency of side affected 
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Frequency of side affected: 
The left kidney was affected in 52% of the cases, the right kidney 
in 40% of the cases and both kidneys in 8% cases. The relationship 
between the side of affection and outcomes were not statistically 
significant in our  study (p=0.850) (Fig 5). 
Associated diabetes mellitus :  
88% of the patients were diabetic of which 8% were newly 
detected.12% of the patients were non diabetic. Diabetic status or 
the absence of it did not have a statistically significant relationship 
with the outcome (0.599) (Fig 6). 
Treatment of diabetes mellitus : 
Of the diabetics, 95% were on regular treatment.90% were on 
OHAs and 5% were on insulin . 5% of patients were on irregular 
treatment. Diabetic treatment and the mode of treatment did not 
reach statistical significance in our study (0.470) (Fig 7). 
Symptoms : 
The  most common mode of presentation was fever & loin pain 
(14/25 ; 56%).Loin pain was the only presentation in 28% (7/25). 
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Frequency of Diabetes
 Yes
)80% (20
 No
)12% (3
)Yes(ND
)8% (2
 
Figure 6: Frequency of diabetes 
Mode of diabetes treatment
 OHA
)90% (18
Irregular
)5% (1
Insulin
)5% (1
 
Figure 7: Mode of diabetes treatment 
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Examination findings
 Abdominal
 distension
)4% (1
Tenderness
)72% (18
Mass
)24% (6
 
Figure 8: Examination findings 
Renal parameters
Raised
)48% (12
Normal
)52% (13
 
Figure 9: Renal parameters 
 
 51
Other modes of presentations like seizures, altered sensorium or 
vomiting constituted the rest (16%). Patient complaints were 
significantly related to the outcome (p=0.034). 
 
Findings at clinical examination : 
On clinical examination, the commonest finding was loin 
tenderness (72%). 24% presented with an abdominal mass and 4% 
with abdominal distension. 
Renal parameters: 
12 out of 25 patients (48%) had raised renal parameters.The rest 
(52%) had normal renal parameters. The mean serum creatinine 
value in the good outcome group was 1.547 with a S.D(standard 
deviation) of 0.786 and in the poor outcome group was 2.450 with 
a s.d of 1.290.The blood urea values in the good outcome group 
was 46.412 +/- 22.875 and in the poor outcome group was 67.429 
+/- 28.136. The relationship of serum creatinine value with the 
outcome reached statistical significance (p=0.040), but not that of 
blood urea (p=0.068).(Fig 9) 
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Shock at presentation : 
6 out of the total 25 patients (24%) presented with shock. The  
relationship of shock with the outcome was statistically significant 
(p=0.002). (Fig 10) 
Mental status on presentation: 
84% patients presented in normal mental status while 
16% had altered mental status on presentation. Out of 4 patients 
with altered mental status, 3 were in the poor outcome group.Thus, 
altered mental status had a statistically significant relationship with 
the outcome( p=0.044). (Fig 11) 
Blood sugar : 
In the present study,the blood sugar value associated with a good 
outcome was 234.059 +/- 85.003 and the value associated with 
poor outcome was 274.250+/- 118.353. Blood sugar values at 
presentation did not show any statistically significant correlation 
with the outcome (0.341). 
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Shock at presentation
No
)76% (19
Yes
)24% (6
 
Figure 10: Shock at presentation 
 
Mental status at presentation
Normal
)84% (21
Altered
)16% (4
 
Figure 11: Mental status at presentation 
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Platelet count: 
In the present study, the mean platelet count was 142400 with a 
S.D of 44654.23. Patients with a good outcome were associated 
with a mean platelet count of 157058.824 with a S.D of 34957.958. 
Poor outcome was associated with mean platelet count of 111250 
with a S.D of 49117.207.The correlation between platelet counts 
and outcome was significant (p=0.013). The patients were further 
stratified into two groups based on whether the platelet count was 
above or below 120000/cmm. In the below 120000/cmm group, 
5/12 were associated with a good outcome and 7/12 were 
associated with a poor outcome. In the above 120000/cmm group, 
12/13 were associated with a good outcome and 1/13 were 
associated with a poor outcome. This reached statistical 
significance with a p value of 0.007. 
Total count: 
The  mean total count (TC) in the present study was 10945.83 with 
a S.D of  2963.98.When correlated with the outcomes, the mean 
TC in the poor outcome group was 14114.286 with a S.D of 
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1193.634 and in the good outcome group was 9641.176 with a 
S>D of  2427.720. The correlation between  blood TC and 
outcomes was statistically significant (p=0.000). When patients 
were further stratified based on whether their total count was above 
or below 10000/cmm, all patients in the below 10000/cmm group 
were associated with a good outcome. In the above 10000/cmm 
group, 6/14 were associated with a good outcome and 8/14 were 
associated with poor outcome. This association reached statistical 
significance (p=0.002). 
Blood Haemoglobin (Hb):  
In the present study, the mean Hb value was 9.94 with a S.D of 
1.53. In good outcome patients, the Hb was 10.282 +/- 1.606. In 
the poor outcome group, the Hb was 9.200 +/- 1.116. There was no 
statistically significant correlation between the Hb value and the 
outcomes (p=0.100). 
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DKA at presentation: 
 2 patients (8%) were in DKA at presentation. No statistically 
significant correlation was found between DKA at presentation and 
outcome (p=0.569) (Fig 12). 
CT classification: 
The following was the distribution of the patients8. 
Class 1 – 4% (1 patient) 
Class 2 – 44% (11 patients) 
Class 3A- 24% (6 patients) 
Class 3B- 16% (4 patients) 
Class 4-12% (3 patients) 
There was no correlation made out between CT class and the 
outcome (p=0.115) (Fig 13). 
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Diabetic ketoacidosis at presentation
No
)92% (23
Yes
)8% (2
 
Figure 12: Diabetes ketoacidosis at presentation 
 CT classification
Class 1
)4% (1
 Class 2
)44% (11 
Class 3A
)24% (6
Class 3B
)16% (4
Class 4
)12% (3
 
Figure 13: CT classification 
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Modes of treatment: 
Antibiotics only was used in 12% of patients. DJ stenting was the 
only modality in 24% of the patients and PCD only in 52%. PCD 
was combined with DJ stenting in 12% of patients.The mode of 
treatment was not significantly related to the outcome (p=0.192). 
Results of urine culture: 
The commonest organism grown in urine culture was E.coli 
(72%).E.coli with Proteus was grown in 4%, and other organisms 
(Klebsiella, Proteus) in 24%.Urine culture result did not correlate 
with the outcome (p=0.435) (Fig 14). 
Results of blood culture: 
Blood cultures were positive in 40% of the cases.Of the 10 patients 
with a positive blood culture, 6 had poor outcome.The relationship 
between blood culture positivity and outcome reached statistical 
significance (p=0.014). (Fig 15) 
 59
Organisms grown in urine culture
E.coli
)72% (18
Proteus
)4% (1
E.coli,Proteus
)4% (1
Klebsiella
)20% (5
 
Figure 14: Organisms grown in urine culture 
 
Frequency of positive blood cultures
Negative
)60% (15
Positive
)40% (10
 
Figure 15: Frequency of positive blood cultures 
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Presence of obstruction: 
In the present study,  urinary tract obstruction was present in 68% 
of patients. 32% patients did not have associated obstruction.Of the 
8 patients who had associated urinary tract obstruction, all the 8 
were associated with good outcome. Of the 17 patients with no 
associated obstruction, 52.94% (9/17) had a good outcome and 
47.05% (8/17) had a poor outcome. Thus the relationship between 
obstruction and outcomes was statistically significant (p=0.019). 
This implies that presence of obstruction when relieved would 
assist  renal conservation.  
Type of outcome: 
68% patients (17/25 ) had a good outcome in the form of renal 
conservation. 32% patients (8/25) had a poor outcome as indicated 
by the loss of the renal unit (Fig 17). 
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Antibiotics given
 Cefotaxim
)20% (5
 & Cefoperazone
Sulbactam
)8% (2
Ceftriaxone
)12% (3
Cefotaxim, AG
)56% (14
Ceftr, AG
)4% (1
 
Figure 16: Antibiotics used. 
Type of outcome
Poor
)32% (8
Good
)68% (17
 
Figure 17: Type of outcome 
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DISCUSSION 
 
 
 
25 patients were included prospectively during the study period. 
The results of the present study were analysed and compared with 
other studies. 
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Fig 18: Comparative study 
 
Sl.
No 
Study Design Sample  Finding 
1. Huang et al8 Prospective 48  Class 1 or 2 & class 3 or 4 with <2 risk 
factors-conservation 
Others-nephrectomy 
2. Michaeli et al6 Retrospective 54  Resuscitation, early antibiotics, relief of 
obstruction & early nephrectomy. 
3. Shokeir et al12 Retrospective 20  Nephrectomy 
4. Bum Soo Park 
Et al5 
Retrospective 17  
 
Conservation in selected cases 
5. Chen et al23 Retrospective 25  Antibiotics with CT guided drainage 
6. Wan et al 19 Retrospective 38  Predictors of high risk – S.Creatinine & 
Platelet count 
 
7. 
 
Present study 
 
prospective 
 
25 
 
Conservation feasible. 
Predictors of poor outcome identified. 
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Age: Mean age in the present study is 55.12 yrs which is 
comparable with other studies 3,5, 6, 7, 8, 12 . 
 
Sex distribution: In our study, there was a female predominance, 
which is seen in other studies also. 
 
Side of involvement: In the present study, there was a 
predominance of left over the right side. In other studies also, a 
similar female predominance is seen. 
 
Presenting complaints: The predominant mode of presentation in 
the present study was fever associated with loin pain. This is 
similar to  other studies.8,12. 
 
Duration of symptoms before presentation: The mean duration 
of symptoms before presentation was 11.60 days in our study. In 
Chen et al’s study 3, it was 18 +/- 8.64 days3. In our study, the 
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mean duration of symptoms before presentation in the good 
outcome group was 12.294 days and in the poor outcome group 
was 10.125 days. In comparison, in Huang et al’s study, the 
duration of symptoms prior to diagnosis in the good outcome 
group was 8.2 days and in the poor outcome group was 6.1 days 8. 
 
Presence of Diabetes mellitus: DM was present in 88% of 
patients in our study which correlates well with the studies of Chen 
et al 3 and Shokeir et al 12.The prevalence of DM in Huang et al’s 
study was 96% 8. 
 
Presence of shock: In the present study,5/8 (62.5%) of the patients 
in poor outcome group presented with shock  and 1/17 (5.88%) of 
the patients in good outcome group presented with shock .In 
comparison, in Huang et al’s study 56% in the poor outcome group 
and 17%  of patients in the good outcome group presented with 
shock 8. 
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Altered mental status at presentation:  In the present study, 3/8 
(37.5%) of the patients in poor outcome group presented with 
altered mental status and 1/17 (5.88%) of the patients in good 
outcome group presented with altered mental status. In 
comparison, in Huang et al’s study 50% in the poor outcome group 
and 3% of patients in the good outcome group presented with 
altered mental status 8. 
 
Altered renal parameters: In the present study, the mean serum 
creatinine in patients with good outcome was 1.547+/-0.786 . The 
mean serum creatinine in patients with poor outcome was2.450+/- 
1.290.This reached statistical significance (p=0.040). Then the 
patients were stratified based on a cut off of serum 
creatinine(1.5mg/dl) and patients analysed with regards to the 
outcome. In the <1.5mg/dl group, 10/12 patients fell under the 
good outcome and 2/12 patients fell under the poor outcome group. 
In the >1.5mg/dl group, 7/13 fell under the good outcome and 6/13 
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patients fell under the poor outcome group. This was statistically 
not significant (p=0.114). 
                Only when cutoff value of serum creatinine was fixed at 
1.4mg%, it reached near statistical significance with a p value of  
0.054. 
 
Management and outcome according to radiological classes: In 
the present study, 100% of patients in class 1(1/1) had a good 
outcome which is comparable with the Huang et al study8.In class 
2, 90.90% patients(10/11) had a good outcome and 9.09% 
patients(1/11) had a poor outcome. This is comparable with the 
Huang et al study8. In class 3A, 50% patients (3/6) had a good 
outcome and 50% patients (3/6) had a poor outcome. In 
comparison, in the Huang et al study8, there was a 100% poor 
outcome. In class 3B, 25% patients (1/4) had a good outcome and 
75% patients(3/4) had a poor outcome. In comparison, in the 
Huang et al study8, there was a 49% poor outcome. In class 4, 
66.66% patients (2/3) had a good outcome and 33.33% 
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patients(1/3) had a poor outcome. In comparison, in the Huang et 
al study8, there was a 75% poor outcome. 
 
Management and outcome 
In the present study, use of antibiotics only was associated with a 
good outcome in 33.33% and a poor outcome in 66.66% patients, 
while in Huang et al’s study, it was associated in 60% and 0% with 
good and poor outcomes respectively8. 
The use of PCD only was associated with a good outcome in 
61.53% and a poor outcome in 38.46% patients, while in Huang et 
al’s study, it was associated in 66% and 20% with good and poor 
outcomes respectively8. 
 In the present study, PCD with DJ stenting was associated with a 
good outcome in 66.66% and a poor outcome in 33.33% patients. 
In patients treated with DJ stenting only, there was a 100% 
successful outcome. 
Urine cultures: In the present study,  E.coli was grown in 72% of 
patients and Klebsiella pneumoniae in 20% of patients. In 
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comparison, in the study of Bum Soo Park et al, 52% grew E.coli 
and 24% grew Klebsiella pneumoniae.In their study, 24% did not 
show any growth in the urine5. 
 
Blood cultures: In the present study, blood cultures were positive 
in 40% of patients. This compares well with Wan et al’s study7 in 
which 42.10% had positive blood cultures but is much less than in 
Bum Soo Park et al’s study5  in which 59%  had positive blood 
cultures. 
 
Obstruction: In the present study, obstruction was present in 32% 
of patients. In this group, when obstruction was relieved, there was 
a 100% association with good outcome. In the good outcome 
group, 47.05% patients had associated obstruction.This contrasts 
with Huang et al’s study in which good outcome group was 
associated with obstruction in 25% patients only8. 
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Platelet count: In the present study, 29.41% of the patients in the 
good outcome group and 87.5% patients in the poor outcome 
group had thrombocytopenia (platelet count < 120000). This is 
comparable to the study by Huang et al8, in which, 28% in the 
good outcome group and 81% in the poor outcome group were 
associated with a platelet count of < 120000. This relationship 
reached statistical significance in both the present and Huang et 
al’s study8. 
 
  Total count:     In the present study, the TC in good outcome 
group was 9641.17 +/- 2427.72 and in the poor outcome group was 
14114.28 +/- 1193.634. In comparison, in the study by Wan et al7, 
the TC in survivors was 13904 +/- 6568 and in nonsurvivors was 
15500 +/- 6601.  
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SUMMARY 
 
Of the total 25 patients included in the study the following were 
the findings. 
• Emphysematous pyelonephritis is commoner in the females. 
• There is a slight predominance of the left over the right side. 
• The most common presenting symptoms were fever and loin 
pain. 
• Emphysematous pyelonephritis predominantly affects the 
diabetics. 
• Patients can present in the emergency with unrelated clinical 
features. 
• Even though USG and Xray KUB can help in diagnosis, the 
most helpful is CT KUB. 
• There is a high incidence of positive urine culture – the most 
common organism being E.coli spp. 
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• When blood cultures are positive, the organisms grown are 
the same as in urine cultures. 
• When there is an underlying urinary tract obstruction, relief 
of the obstruction assists renal conservation. 
• Various treatment modalities like antibiotics, PCD, DJ 
stenting either alone or in combination make renal 
conservation feasible in 68% of patients. 
• Clinical factors like shock or altered mental status at 
presentation, absence of associated urinary tract obstruction, 
laboratory parameters like raised serum creatinine, raised TC, 
positive blood cultures, reduced platelet counts are all 
significant factors in determining  the outcome during  
attempted renal conservation. 
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CONCLUSIONS 
 
1) There is a definite role for renal conservation in properly 
selected patients of emphysematous pyelonephritis. 
2) The following factors at presentation could tilt the balance 
towards nephrectomy in conservatively managed cases of  
emphysematous pyelonephritis 
• Shock  
• Altered mental status  
• Raised serum creatinine 
• Total count >10000/cmm 
• Platelet count < 120000/cmm 
• Positive blood cultures 
• Absence of urinary tract obstruction. 
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PHOTOGRAPHS 
 
Fig 19:  Xray KUB showing gas in Lt renal area 
 
Fig 20: Xray KUB showing gas in Lt renal area 
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Fig 21: USG KUB 
 
Fig 22: CT KUB Class 2 EPN 
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                    Fig 23: CT KUB Class 3A EPN 
 
Fig 24: CT KUB Class 3B EPN 
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Fig 25: CT KUB-reconstructed image  
 
Fig 26: Retrieved necrosed renal papilla 
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Fig 27: Nephrectomy  in progress 
 
Fig 28: Cut section of left kidney post nephrectomy 
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ABBREVIATIONS 
 
DM :                  Diabetes mellitus 
UTI :                  Urinary tract infection 
EPN :                 Emphysematous pyelonephritis 
E.coli :               Escherichia coli 
K.pneumoniae : Klebsiella pneumoniae 
B.fragilis :         Bacteroides fragilis 
ATP :                Adenosine tri phosphate 
NAD :               Nicotinamide adenine dinucleotide 
USG :                Ultrasonogram 
CT scan:            Computerised Tomographic scan 
IVU :                 Intravenous urogram 
SD :                   Standard deviation 
TC  :                  Total count 
Hb  :                   Haemoglobin 
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